A lateral flow immunoassay test card intended for qualitative detection of SARS-CoV-2 nucleocapsid protein with FDA EUA authorization. The rapid test provides quick diagnostic results for COVID-19 detection.
Manufactured by
Xiamen, Fujian, China
Specializes in developing and manufacturing in vitro diagnostic kits, including point of care and immunoassay products for global markets. Operates a 12,500 square meter facility under ISO 13485:2016 and GMP guidelines, with products approved by China NMPA and exported to over 70 countries. Focuses on diagnostic rapid tests and offers customized solutions alongside comprehensive technical support services.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Futura System Group S.r.l.
Italy · 1 relevant product
Syntesys S.R.L.
Italy · 1 relevant product
Fosun Diagnostics (Shanghai) Co., Ltd
China · 1 relevant product
Genrui Biotech Inc.
China · 1 relevant product
AccuBioTech Co., Ltd.
China · 1 relevant product
Bioantibody Biotechnology Co., Ltd.
China · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
Hangzhou Lysun Biotechnology Co.,Ltd
China · 1 relevant product
Xiamen Biotime Biotechnology Co., Ltd.
China · 3 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 3 relevant products
78 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Futura System Group S.r.l. · Italy
Immunochromatographic assay for qualitative detection of SARS-CoV-2 antigen using nasopharyngeal swabs from symptomatic patients.
Syntesys S.R.L. · Italy
A rapid diagnostic test card for the detection of COVID-19 antigens in saliva samples. This test provides quick results for SARS-CoV-2 screening and is designed for point-of-care testing applications.
Fosun Diagnostics (Shanghai) Co., Ltd · China
An immunochromatographic test kit for the detection of Covid-19 antigens. This product is designed for rapid diagnostic testing of Covid-19 infection.
Genrui Biotech Inc. · China
Rapid diagnostic test for qualitative detection of SARS-CoV-2 antigen or serology markers. Available in serological and antigen formats for point-of-care testing applications.
AccuBioTech Co., Ltd. · China
A rapid immunochromatographic test for the qualitative detection of SARS-CoV-2 antigens, enabling quick screening and diagnosis in clinical and point-of-care settings.
Bioantibody Biotechnology Co., Ltd. · China
Rapid immunoassay test for detection of SARS-CoV-2 infection. Provides quick results for COVID-19 screening and diagnosis.
U-GEN BIOTECHNOLOGY INC. · China
SARS-CoV-2 Antigen Rapid Test is an in vitro diagnostic test kit for rapid detection of SARS-CoV-2 antigens. The test provides quick results for COVID-19 screening and diagnosis in clinical and point-of-care settings. Designed for high sensitivity and specificity to support infection control and patient management.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A rapid visual immunoassay for qualitative detection of SARS-CoV-2 antigens. Designed for self-testing and point-of-care diagnosis of COVID-19 infection.
Xiamen Biotime Biotechnology Co., Ltd. · China
Rapid qualitative diagnostic test for detection of SARS-CoV-2 antigen in clinical specimens.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid diagnostic test for detection of SARS-CoV-2 antigen. Provides quick identification of active COVID-19 infection for point-of-care testing.
Dialab GmbH · Austria
Rapid antigen test kit for qualitative detection of SARS-CoV-2 in clinical specimens. Designed for point-of-care and laboratory testing with fast turnaround time. Enables quick identification of active COVID-19 infection to support clinical decision-making and infection control.
AssureTech.(Hangzhou) Co.,Ltd. · China
Rapid antigen detection device for COVID-19 diagnosis at point-of-care settings. Delivers qualitative results to identify active SARS-CoV-2 infection from respiratory samples. Designed for clinical and screening applications requiring quick turnaround times.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products